Xiaochun Liu

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E…

Journal of Clinical Oncology · 2024 · 323 citations

miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells

Cell Death and Differentiation · 2010 · 211 citations